Skip to content

Biolab & Co

Brazilian pharmaceutical group integrating science, innovation and industry across human health, veterinary health and animal nutrition.

Last updated September 11, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Biolab & Co is described on its official site as a Brazilian pharmaceutical group that integrates science, innovation and industry to develop therapeutic solutions. It states that it operates in human health, veterinary health and animal nutrition, and that the group brings together six brands and a portfolio of more than 900 products structured in the business units Biolab Farmacêutica, Biolab Genéricos, Avert Saúde Humana, Avert Biolab Saúde Animal, Exzell Pharma and Pet Nutrition. The company reports productive units in São Paulo and Minas Gerais, as well as Research, Development and Innovation (RD&I) centers in Brazil and Canada, and states it has more than 50 international partnerships and more than 400 patent applications. Its homepage highlights a 2025/2026 Sustainability Report, digital accessibility, and international expansion through the acquisition of Exzell, establishing an export platform from Canada.

History

Biolab & Co describes itself as a Brazilian pharmaceutical group that integrates science, innovation and industry to develop therapeutic solutions promoting health and quality of life. It states that it operates in human health, veterinary health and animal nutrition, and that the group brings together six brands and a portfolio of more than 900 products structured in the business units Biolab Farmacêutica, Biolab Genéricos, Avert Saúde Humana, Avert Biolab Saúde Animal, Exzell Pharma and Pet Nutrition. The company reports productive units in São Paulo and Minas Gerais, as well as Research, Development and Innovation (RD&I) centers in Brazil and Canada, and states it has more than 50 international partnerships and more than 400 patent applications. Its homepage announces international expansion through the acquisition of Exzell, establishing an export platform from Canada, and highlights a 2025/2026 Sustainability Report and digital accessibility initiatives.

Products and positioning

A Brazilian pharmaceutical group aiming to be a reference among Brazilian pharmaceutical groups, transforming innovation into greater access to health and well-being.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/biolab-pharma-brazil · Editorial policy · How profiles are compiled